Actively Recruiting

Age: 18Years - 70Years
All Genders
Healthy Volunteers
NCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

Led by San Francisco Veterans Affairs Medical Center · Updated on 2024-08-02

150

Participants Needed

1

Research Sites

221 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses reward-related information. However, reward processing is a complex, multi-circuit phenomenon, and the precise neural mechanisms that contribute to the absence or reduction of pleasure and motivation are not well understood. Variation in the clinical presentation of depression has long been a rule rather than an exception, including individual variation in symptoms, severity, and treatment response. This heterogeneity complicates understanding of depression and thwarts progress toward disease classification and treatment planning. Discovery of depression-specific biomarkers that account for neurobiological variation that presumably underlies distinct clinical manifestations is critical to this larger effort.

CONDITIONS

Official Title

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

Who Can Participate

Age: 18Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 70 years
  • Diagnosis of major depressive disorder for MDD group or no diagnosis for healthy comparison group
  • Negative metal screening for MRI safety
  • Normal or corrected-to-normal vision
Not Eligible

You will not qualify if you...

  • Past or present neurological problems including seizures or head trauma with symptoms
  • Loss of consciousness longer than 30 minutes or with neurological symptoms
  • Major medical conditions such as seizure disorders, endocrine disorders, or significant heart problems
  • Substance dependence within the past year or positive urine toxicology on neuroimaging days
  • Known claustrophobia
  • Current pregnancy
  • IQ estimate below 70

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

San Francisco Healthcare System

San Francisco, California, United States, 94121

Actively Recruiting

Loading map...

Research Team

J

Jason Hemmerle, MBA

CONTACT

K

Kaitlyn Dal Bon, BA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here